Reaction

Spondyloarthropathy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 589 reports · 18 co-occurring drugs

As of the last recalculation, Spondyloarthropathy appears in 589 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is DESOXIMETASONE (PRR 50.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Desoximetasone2650.450.5
Diclofenac Potassium, Film Coated1042.742.8
Diclofenac Potassium Tablets1042.742.7
Adalimumab-Fkjp4940.740.7
Adalimumab-Aaty4939.839.9
Adalimumab-Adaz5137.337.3
Naproxen6834.534.5
Diclofenac Potassium1033.233.3
Canakinumab1033.233.2
Sulfasalazine5929.529.5
Anakinra1226.126.1
Prochlorperazine Maleate623.223.3
Certolizumab Pegol6521.921.9
Secukinumab8521.621.6
Vedolizumab4017.517.5
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose417.417.4
Golimumab3113.413.4
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride910.410.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.